Cargando…
Constructed Tumor-Targeted and MMP-2 Biocleavable Antibody Conjugated Silica Nanoparticles for Efficient Cancer Therapy
[Image: see text] Antibody–drug conjugates (ADC) are an inevitable trend in the development of modern “precision medicine”. The goal of this work is to produce enzyme-responsive antibody nanoparticle-loaded medication (FMSN-Dox-H2-AE01) based on the EGFR antibody (AE01) and human serum albumin (HSA)...
Autores principales: | Wu, Hao, Ding, Xuefeng, Chen, Yun, Cai, Yanfei, Yang, Zhaoqi, Jin, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099448/ https://www.ncbi.nlm.nih.gov/pubmed/37065049 http://dx.doi.org/10.1021/acsomega.2c07949 |
Ejemplares similares
-
Biocleavable Polycationic Micelles as Highly Efficient Gene Delivery Vectors
por: Zhang, Min, et al.
Publicado: (2010) -
Amelioration of hepatotoxicity by biocleavable aminothiol chimeras of isoniazid: Design, synthesis, kinetics and pharmacological evaluation
por: Bhilare, Neha Vithal, et al.
Publicado: (2018) -
Lysosomal-specific Cholesterol Reduction by Biocleavable Polyrotaxanes for Ameliorating Niemann-Pick Type C Disease
por: Tamura, Atsushi, et al.
Publicado: (2014) -
Anti-EGFR antibody conjugated silica nanoparticles as probes for lung cancer detection
por: Wan, Jun, et al.
Publicado: (2017) -
Oral Cancer Theranostic Application of FeAu Bimetallic Nanoparticles Conjugated with MMP-1 Antibody
por: Tsai, Meng-Tsan, et al.
Publicado: (2021)